Heron Therapeutics Balance Sheet - Quarterly (NASDAQ:HRTX)

Add to My Stocks
$33.1 $0.6 (1.78%) HRTX stock closing price Sep 20, 2018 (Closing)

The financial analysis of a company like Heron Therapeutics involves checking the three financial statements of the company in detail, of which the balance sheet is one. All three financial statements should be used to measure the financial performance of the company, and should form a part of the Heron Therapeutics stock analysis. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. The Heron Therapeutics balance sheet for 2018 Q2 shows total assets of $510.56M. The company has a asset turnover ratio of 0.2. Also see: Heron Therapeutics revenue and Heron Therapeutics operating cash flow for the same quarter.

View and download Heron Therapeutics quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Cash258.93M46.57M144.58M65.52M30.27M83.51M13.41M45.64M61.94M68.01M
Marketable Securities164.03M67.36M27.79M8.49M78.98M81.7M37.72M43.27M12.7M32.39M
Receivables45.89M37.71M41.87M28.85M18.61M10.32M1.96M---
Inventory27.2M19.41M10.1M5.16M4.8M4.64M5.34M1.98M3.31M2.74M
Raw Materials--2.75M---1.64M---
Work In Progress--4.16M---1.1M---
Finished Goods--3.18M---2.58M---
Notes Receivable----------
Other Current Assets6.58M5.49M3.7M4.55M3.67M3.43M3.7M3.07M3.17M5.05M
Total Current Assets
502.62M176.56M228.06M112.59M136.35M183.61M62.14M93.97M81.13M108.2M
Property Plant & Equipment--13.84M---11.69M---
Accumulated Depreciation--7.85M---6.61M---
Net Property Plant & Equipment
7.51M6.5M5.98M5.34M5.75M5.68M5.07M4.7M4.47M3.64M
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Intangibles----------
Deposits & Other Assets----------
Total Assets
510.56M183.38M234.3M118.19M142.37M189.55M67.48M98.8M85.73M111.84M
Notes Payable29.11M28.68M2.91M2.22M1.59M1.02M----
Accounts Payable4.98M11.45M18.76M5.33M6.31M4.47M6.81M6.09M8.66M6.86M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses44.57M50.82M52.95M38.76M33.9M24.59M27.9M22.1M16.67M9.92M
Income Taxes Payable----------
Other Current Liabilities--2.76M5.56M4.78M5.23M1.09M---
Total Current Liabilities
78.67M91.17M103.17M53.14M48.29M37.39M38.73M30.92M27.89M19.17M
Mortgages----------
Deferred Taxes/Income----------
Convertible Debt----------
Long-Term Debt---25M25M50M50M50M--
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
78.67M91.17M103.17M78.14M73.29M87.39M88.73M80.92M27.89M19.17M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus1.3B925.74M913.95M760.47M747.64M737.95M564.34M555.51M546.95M538.58M
Retained Earnings-872.82M-834.14M-783.45M-720.96M-679.09M-636.3M-585.97M-538M-489.49M-446.27M
Treasury Stock----------
Other Liabilities-0.03M-0.04M-0.01M--0.01M-0.03M-0.01M-0.01M--
Shareholders Equity431.89M92.2M131.13M40.05M69.07M102.16M-21.25M17.88M57.84M92.67M
Total Liabilities & Shareholders Equity510.56M183.38M234.3M118.19M142.37M189.55M67.48M98.8M85.73M111.84M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Most investors just check the Heron Therapeutics stock price, and Heron Therapeutics historical stock prices before investing. While share price is an important factor, one should also look at financials and valuation metrics like the Heron Therapeutics PE ratio chart. Below is a brief explanation of common balance sheet terms:

  • Assets: Anything that the Heron Therapeutics company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Heron Therapeutics had total assets of $510.56M.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. HRTX stock had total liabilities of $78.67M for the quarter 2018 Q2.

Heron Therapeutics Balance Sheet - Key Ratios

Current ratio
6.39
Debt to equity ratio
0.07
Asset turnover ratio
0.2
Receivables turnover
1.37
Price to book ratio
15.58